Skip to content
Immunophotonics
  • About
    • Team
    • Board of Directors
    • Advisory Board
    • Highlighted Co-Inventor
    • Collaborators
  • Technology
  • Interventional Immuno-Oncology®
  • Clinical Trials
    • Colorectal Cancer (CRC)
    • Non-Small Cell Lung Cancer (NSCLC)
    • Melanoma
    • Soft Tissue Sarcoma (STS)
    • Hepatocellular Carcinoma (HCC)
    • Pancreatic Cancer
    • Vaccine Adjuvant
  • Patients
  • News & Media
  • Contact Us
Menu

News

404

News & Media

  •          
  • Print
Home » News & Media
Latest News

Bio-Europe 2022, October 24 – 26

November 10, 2022
Dr. Theresa Visarius, Immunophotonics Vice President of Business Development and Managing Director of Immunophotonics Switzerland will be attending Bio-Europe 2022…
Read More
Latest News

BioPharm America 2022 September 28 & 29

November 10, 2022
Lu Alleruzzo, Co-Founder & CEO, at Immunophotonics, Inc., will be attending the BioPharm America 2022 conference in Boston on September…
Read More
Latest News

RESI Boston 2022 Partnering Platform

September 20, 2022
Lu Alleruzzo, Co-Founder & CEO, at Immunophotonics, Inc. will be attending the RESI Boston 2022 Partnering Platform, September 21st &…
Read More
Latest News

SACHS Associates 22nd Annual Biotech in Europe Forum

September 20, 2022
Dr. Theresa Visarius, Immunophotonics Vice President Business Development and Managing Director of the Swiss subsidiary IPS Biopharma AG will be…
Read More
Latest News

Cardiovascular and Interventional Radiology Society of Europe (CIRSE) Conference

September 22, 2022
Tomas Hode, PhD, Co-Founder, CIO, and President at Immunophotonics, Inc. attended the Cardiovascular and Interventional Radiology Society of Europe (CIRSE)…
Read More
Latest News

European Society of Medical Oncology (ESMO) Congress

September 22, 2022
Lu Alleruzzo, Co-Founder & CEO at Immunophotonics, Inc. attended the European Society of Medical Oncology (ESMO) Congress in Paris, France…
Read More
Latest News Press Releases

Immunophotonics Announces Appointment of New Chief Medical Officer and Chief Scientific Officer

September 1, 2022
Immunophotonics, Inc. is thrilled to announce the addition of Dr. Edwina Baskin-Bey in the role of Chief Medical Office (CMO)…
Read More
Latest News

Tomas Hode, Wei R. Chen, Siu Kit “Samuel” Lam T Cell Paper Publication

August 9, 2022
Immunophotonics would like to congratulate Ashley Hoover and Kaili Liu lead authors from the University of Oklahoma and to the…
Read More
Latest News

Swiss MedTech Day June 14, 2022

November 10, 2022
Dr. Theresa Visarius, VP of Business Development at Immunophotonics, Inc. will be attending 2022 Swiss MedTech Day on Tuesday, June…
Read More
Latest News

Society of Interventional Radiology Annual Scientific Meeting (SIR), June 11-16, 2022

June 13, 2022
Tomas Hode, PhD, Co-Founder, CIO, and President at Immunophotonics, Inc. will be attending the Society of Interventional Radiology Annual Scientific…
Read More
« Previous 1 … 9 10 11 12 13 14 Next »
Contact us for more info and updates
  • About
  • Team
  • Board of Directors
  • Advisory Board
  • Highlighted Co-Inventor
  • Collaborators
  • Technology
  • Clinical Trials
  • Colorectal Cancer (CRC)
  • Non-Small Cell Lung Cancer (NSCLC)
  • Melanoma
  • Soft Tissue Sarcoma (STS)
  • Hepatocellular Carcinoma (HCC)
  • Pancreatic Cancer
  • Vaccine Adjuvant
  • Patients
  • Background
  • Trial Summary

Quick Links

  • Interventional Immuno-Oncology®
  • News & Media
  • Careers
  • Contact Us
  • Privacy Policy
  • Site Map
© Immunophotonics, Inc. All Rights Reserved
Terms of Use | FCOI Policy
Website by Axxiem
Scroll to top